Pathobiology and cell interactions of platelets in diabetes (Q36320564)

13 August 2017

1 reference

title

Pathobiology and cell interactions of platelets in diabetes (English)

1 reference

13 August 2017

Bernd Stratmann

1 reference

13 August 2017

Diethelm Tschoepe

series ordinal

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Diabetes and Vascular Disease Research

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

16-23

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Diabetes Mellitus and Cardiovascular Disease in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Insulin resistance and systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Insulin, cation metabolism and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet dysfunction in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

The role of platelets in diabetes-related vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Clinical Trials of Antiplatelet Agents in Diabetes Mellitus: Rationale and Results

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Thrombopoietin and hematopoietic stem cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Induction of platelet formation from megakaryocytoid cells by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet adhesion to collagen under flow conditions in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Thromboxane biosynthesis and platelet function in type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Expression of Adhesion Molecules on the Surface of Activated Platelets is Diminished by PGI(2)-analogues and an NO (EDRF)-Donor: A Comparison Between Platelets of Healthy and Diabetic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet Resistance to Nitrates in Obesity and Obese NIDDM, and Normal Platelet Sensitivity to Both Insulin and Nitrates in Lean NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure. A possible link to increased cardiovascular mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Differential alterations of spontaneous and stimulated 45Ca(2+) uptake by platelets from patients with type I and type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Increased platelet volume--sign of impaired thrombopoiesis in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet plasminogen activator inhibitor 1 in patients with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Heart disease in diabetes mellitus: A challenge for early diagnosis and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor γ‐chain

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

A Novel Association of Fc Receptor γ-Chain with Glycoprotein VI and Their Co-expression as a Collagen Receptor in Human Platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Influence of platelet size on outcome after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet glycoprotein IIb. Chromosomal localization and tissue expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

The megakaryocyte platelet system and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Increased GPIIB/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet turnover in advanced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Genetic variation of the platelet- surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Homozygosity for 807 T polymorphism in alpha(2) subunit of platelet alpha(2)beta(1) is associated with increased risk of cardiovascular mortality in high-risk women

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Characterization of Inherited Differences in Transcription of the Human Integrin alpha 2 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Allele-dependent transcriptional regulation of the human integrin alpha2 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Modulation of monocyte-endothelial cell interactions by platelet microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Prevention of Activated Neutrophil Adhesion to Endothelium by Soluble Adhesion Protein GMP140

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet-leukocyte cross talk in whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet-Leukocyte-Cross-Talk in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Thromboxane biosynthesis and platelet function in type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Platelet and coagulation factors in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Diabetes mellitus: a hypercoagulable state

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Risk Factors for Stroke in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

Nonenzymatic Glycation of Platelet Proteins in Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.001

21 January 2018

Identifiers

DOI

10.3132/DVDR.2005.001

1 reference

13 August 2017

1 reference